Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-687-7 | CAS number: 109-61-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
oral LD50: 1000 - 1470 mg/kg (rat)
inhalative LC50: 1.6 mg/L/1h (rat)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
Additional information
Oral:
In an OECD TG 401 study, Sprague-Dawley rats (5/sex/dose) were administered 46.4, 100, 147, 681, 1000, 1470, 2150 or 3160 mg/kg bw propyl chloroformate by gavage (vehicle; olive oil). The acute oral LD50was 1210 mg/kg bw (95% CL =1055.4 - 1391.3 mg/kg bw). Except for aggressiveness at 147 mg/kg, no clinical effects or mortality were seen at first three doses. Clinical signs of dyspnoea, apathy, and staggering were observed at higher concentrations. At 681 and 1000 mg/kg, 1/10 animals died. Mortality occurred in 9/10 animals at 1470 mg/kg. All animals died at higher doses. In animals that died, necropsy revealed necrotic white mucosa in the stomach and intestine (BASF AG, 1980).
Inhalation:
Study is comparable with the inhalation hazard test described in the Annex of OECD Guideline 403 (adopted 1981)with acceptable restrictions mostly due to reduced reporting in times before GLP. Rats were exposed for 3 min and 1 h, respectively, to a vapour saturated atmosphere. Concentration was stated in the raw data to be 1.385 mg/L in the case of the 3 min exposure and 1.019 mg/L in case of the 1 h exposure. A measured concentration of 40 ppm of phosgen above the test substance in the 3 min trial indicates a partial hydrolisation of the test substance. 12/12 animals died within 2 h after 3 min exposure to 1.385 mg/L; 3/10 animals died within 6d after 1h exposure to 1.019 mg/L.
Animals of the 3 min exposure showed vigorous attempts to escape, extremely severe irritation to the mucosa and gasping; animals of the 1 h exposure showed restlessness, irritation to the mucosa and dyspnea.
Necropsy findings were congestion and edema of the lungs in the 3 min treatment and acute pulmonary emphysema in the 1 h treatment, respectively (BASF 1970).
In an inhalation study comparable to OECD TG 403, rats (5/sex/dose) were exposed by whole-body inhalation for 1 hour to 0.97, 1.3, 3.9, 12 or 84 mg/L propyl chloroformate vapor (nominal concentration). No mortality or clinical signs were noted at 0.97 mg/L. At 1.3 mg/L, 2/10 animals died and bloody nasal discharge and dyspnea were observed. All animals exposed to higher concentrations died. Dose-dependent hyperemia of the lung was observed at necropsy of in all surviving and deceased animals (IBT, 1970). The LC50was 1.6 mg/L/1h. According to CLP No. 1272/2008 Part 3.1.2, for the conversion from 1 h to 4 h exposure, the data are divided by factor 2
Dermal:
No adequate acute dermal toxicity data.
New Zealand White rabbits (2/sex/dose) were dermally treated with 6.8 or 10.2 g/kg bwpropyl chloroformate. There were no deaths at 6.8 g/kg bw. Two animals died at 10.2 g/kg bw. Severe irritation, edema, and burns were observed at the end of the 24-hour exposure period. Six days later, the skin was necrotic. Surviving animals did not gain weight. The dermal LD50was approximately 10.2 g/kg bw (IBT, 1970).
Justification for classification or non-classification
Based on the results of the acute toxicity testing, the test item is classified as acute oral cat. 4 (H302) and acute inhalation cat. 2 (H330) according to Regulation (EC) No 1272/2008 (CLP).
Nevertheless, the substance is classification is according to the legally binding classification in Annex VI to EU Regulation 1272/2008 as acute inhalation cat 3 (H331).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.